Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
110.71
-0.63 (-0.57%)
Nov 21, 2024, 2:04 PM EST - Market open
Revvity Employees
Revvity had 11,500 employees as of December 31, 2023. The number of employees decreased by 5,200 or -31.14% compared to the previous year.
Employees
11,500
Change (1Y)
-5,200
Growth (1Y)
-31.14%
Revenue / Employee
$236,657
Profits / Employee
$22,113
Market Cap
13.47B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 11,500 | -5,200 | -31.14% |
Dec 31, 2022 | 16,700 | 0 | - |
Dec 31, 2021 | 16,700 | 2,700 | 19.29% |
Dec 31, 2020 | 14,000 | 1,000 | 7.69% |
Dec 31, 2019 | 13,000 | 500 | 4.00% |
Dec 31, 2018 | 12,500 | 1,500 | 13.64% |
Dec 31, 2017 | 11,000 | 3,000 | 37.50% |
Dec 31, 2016 | 8,000 | 0 | - |
Dec 31, 2015 | 8,000 | 300 | 3.90% |
Dec 31, 2014 | 7,700 | 100 | 1.32% |
Dec 31, 2013 | 7,600 | 100 | 1.33% |
Dec 31, 2012 | 7,500 | 300 | 4.17% |
Dec 31, 2011 | 7,200 | 1,000 | 16.13% |
Dec 31, 2010 | 6,200 | -2,000 | -24.39% |
Dec 31, 2009 | 8,200 | 300 | 3.80% |
Dec 31, 2008 | 7,900 | -800 | -9.20% |
Dec 31, 2007 | 8,700 | 200 | 2.35% |
Dec 31, 2006 | 8,500 | 500 | 6.25% |
Dec 31, 2005 | 8,000 | -2,000 | -20.00% |
Dec 31, 2004 | 10,000 | 0 | - |
Dec 31, 2003 | 10,000 | -700 | -6.54% |
Dec 31, 2002 | 10,700 | -100 | -0.93% |
Dec 31, 2001 | 10,800 | -1,700 | -13.60% |
Dec 31, 2000 | 12,500 | 500 | 4.17% |
Dec 31, 1999 | 12,000 | -1,000 | -7.69% |
Dec 31, 1998 | 13,000 | -1,000 | -7.14% |
Dec 31, 1997 | 14,000 | -1,000 | -6.67% |
Dec 31, 1996 | 15,000 | 0 | - |
Dec 31, 1995 | 15,000 | -10,000 | -40.00% |
Dec 31, 1994 | 25,000 | -7,000 | -21.88% |
Dec 31, 1993 | 32,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Fresenius Medical Care AG | 119,845 |
Tenet Healthcare | 106,500 |
Universal Health Services | 96,700 |
DaVita | 70,000 |
Avantor | 7,570 |
Moderna | 5,600 |
Incyte | 2,524 |
Genmab | 2,204 |
RVTY News
- 1 day ago - Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK - Business Wire
- 2 days ago - Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference - Business Wire
- 2 days ago - Scale Biosciences and Revvity's BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells - Business Wire
- 3 days ago - Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation - Business Wire
- 16 days ago - These Analysts Revise Their Forecasts On Revvity Following Q3 Results - Benzinga
- 17 days ago - Revitty (RVTY) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Revvity cuts 2024 revenue forecast amid biotech spending slowdown - Reuters
- 17 days ago - Revvity Announces Financial Results for the Third Quarter of 2024 - Business Wire